NEWSROOM
-
Title
-
- Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study
- Shanghai center tests nuclear medicine prostate cancer treatment
- Innovative scale developed to guide locally advanced thyroid cancer treatment
- Robotic surgery innovation center enhances prostate cancer treatment
- China-developed radiation equipment receives international recognition
- First PRRT clinical trial launched in Shanghai
- More accurate prediction of recurrence risk! The FUSCC team provides new "weapon" for postoperative management of colorectal cancer patients
- FUSCC-NMRRC joint webinar on “The treatment of oligo metastatic prostate cancer”
- Fudan University Shanghai Cancer Center revealed a unique T cell subset in the immune microenvironment of HPV-positive oropharyngeal carcinoma
- The study “clinical value of 68Ga-FAPI PET/CT in platinum-sensitive recurrent ovarian cancer” performed by Nuclear Medicine Department of Shanghai Cancer Center has been recognized internationally
